(Total Views: 507)
Posted On: 03/24/2021 12:05:17 PM
Post# of 165
$TAUG Tauriga Sciences Inc. Expands its Pet Treats Product Offerings to 3 SKUs (Branded as: Tauri-Pet)
https://finance.yahoo.com/news/tauriga-scienc...00666.html
The 3 Distinct Tauri-Pet™ SKUs
Commercial Launch of Tauri-Pet™ Product Line is Anticipated: April 20, 2021
NEW YORK, NY, March 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant), additional product offerings, as well as an ongoing Pharmaceutical Development initiative, today announced that it has expanded its pet treats product offerings to 3 distinct Stock-Keeping Units (“SKUs”). These SKUs are as follows: Peanut Butter Flavor dog treats / infused with 5mg CBD (MSRP: $24.99 per bag), Apple Flavor dog treats / all-natural flavor (MSRP: $14.99 per bag), and Butternut Squash Flavor dog treats / fortified with calcium (MSRP: $14.99 per bag). Each bag of Tauri-Pet™ dog treats contains 30 treats (net weight: 4 oz.).
Tauri-Pet™ Product Link(s):
A. Peanut Butter Flavor (Please See Below Link):
https://taurigum.com/products/peanut-butter-cbd-dog-treats
B. Apple Flavor (Please See Below Link
:
https://taurigum.com/products/apple-dog-treats
C. Butternut Squash Flavor (Please See Below Link):
https://taurigum.com/products/butternut-squash-dog-treats
This expansion is the result of substantial levels of interest in this product line, exhibited by a number of prospective customers. The Company believes that the pet treat segment represents a potentially lucrative niche market opportunity. And the Company is confident that the commercial launch of its Tauri-Pet™ product line will help drive revenue growth for the remainder of calendar year 2021 and beyond.
Lastly the Company is in the process of registering Trademark(s) for its Tauri-Pet™ product line, with both the United States Patent & Trademark Office (“USPTO”) and the European Union Intellectual Property Office (“EUIPO”).
https://finance.yahoo.com/news/tauriga-scienc...00666.html
The 3 Distinct Tauri-Pet™ SKUs
Commercial Launch of Tauri-Pet™ Product Line is Anticipated: April 20, 2021
NEW YORK, NY, March 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant), additional product offerings, as well as an ongoing Pharmaceutical Development initiative, today announced that it has expanded its pet treats product offerings to 3 distinct Stock-Keeping Units (“SKUs”). These SKUs are as follows: Peanut Butter Flavor dog treats / infused with 5mg CBD (MSRP: $24.99 per bag), Apple Flavor dog treats / all-natural flavor (MSRP: $14.99 per bag), and Butternut Squash Flavor dog treats / fortified with calcium (MSRP: $14.99 per bag). Each bag of Tauri-Pet™ dog treats contains 30 treats (net weight: 4 oz.).
Tauri-Pet™ Product Link(s):
A. Peanut Butter Flavor (Please See Below Link):
https://taurigum.com/products/peanut-butter-cbd-dog-treats
B. Apple Flavor (Please See Below Link
: https://taurigum.com/products/apple-dog-treats
C. Butternut Squash Flavor (Please See Below Link):
https://taurigum.com/products/butternut-squash-dog-treats
This expansion is the result of substantial levels of interest in this product line, exhibited by a number of prospective customers. The Company believes that the pet treat segment represents a potentially lucrative niche market opportunity. And the Company is confident that the commercial launch of its Tauri-Pet™ product line will help drive revenue growth for the remainder of calendar year 2021 and beyond.
Lastly the Company is in the process of registering Trademark(s) for its Tauri-Pet™ product line, with both the United States Patent & Trademark Office (“USPTO”) and the European Union Intellectual Property Office (“EUIPO”).
(0)
(0)
